Table 1 Baseline characteristics of the patients
Feature_name | ALL | Train | Val | Test |
|---|---|---|---|---|
Age | 63.63 ± 9.36 | 63.40 ± 8.87 | 62.81 ± 9.68 | 68.70 ± 11.18 |
Sex | ||||
Male | 221(82.46) | 141(81.50) | 63(84.00) | 17(85.00) |
Female | 47(17.54) | 32(18.50) | 12(16.00) | 3(15.00) |
Pathology | ||||
LUAD | 144(53.73) | 91(52.60) | 46(61.33) | 7(35.00) |
LUSC | 105(39.18) | 73(42.20) | 24(32.00) | 8(40.00) |
Other | 19(7.09) | 9(5.20) | 5(6.67) | 5(25.00) |
Stage | ||||
III | 82(30.60) | 52(30.06) | 28(37.33) | 2(10.00) |
IV | 186(69.40) | 121(69.94) | 47(62.67) | 18(90.00) |
Eval | ||||
0 | 2(0.75) | 2(1.16) | Null | Null |
1 | 42(15.67) | 26(15.03) | 10(13.33) | 6(30.00) |
2 | 21(7.84) | 8(4.62) | 4(5.33) | 9(45.00) |
3 | 203(75.75) | 137(79.19) | 61(81.33) | 5(25.00) |